BACKGROUND: Decreased hippocampal volume is described in posttraumatic stress disorder (PTSD) and depression. However, it is not known whether it is a risk factor for the development of PTSD or a consequence of PTSD. We sought to determine the effects of PTSD and depressive symptoms on hippocampal volume. METHODS: Clinical and magnetic resonance imaging data were collected in a cross sectional study of 244 Gulf War veterans. Measures included lifetime and current Clinician Administered PTSD Scale, Hamilton Depression Scale, Life Stressor Checklist, and Lifetime Drinking History. Magnetic resonance imaging data were acquired with a 1.5-T scanner and analyzed with automated and semiautomated image processing techniques. RESULTS: Eighty-two veterans had lifetime PTSD, 44 had current PTSD, and 38 had current depression. In the linear regression analysis, current PTSD symptoms (standardized coefficient β = -.25, p = .03) but neither lifetime PTSD symptoms nor current depression were associated with smaller hippocampal volume. Gender, age, history of early life trauma, education, lifetime and current alcohol use, current marijuana use, and treatment with antidepressants did not have independent effects. Participants with chronic PTSD had, on average, a smaller hippocampus compared with those with remitted PTSD. CONCLUSIONS: The finding that current but not lifetime PTSD symptom severity explains hippocampal size raises two possibilities: either a small hippocampus is a risk factor for lack of recovery from PTSD (trait) or PTSD effects on hippocampal volume are reversible once PTSD symptoms remit and the patient recovers (state).
BACKGROUND: Decreased hippocampal volume is described in posttraumatic stress disorder (PTSD) and depression. However, it is not known whether it is a risk factor for the development of PTSD or a consequence of PTSD. We sought to determine the effects of PTSD and depressive symptoms on hippocampal volume. METHODS: Clinical and magnetic resonance imaging data were collected in a cross sectional study of 244 Gulf War veterans. Measures included lifetime and current Clinician Administered PTSD Scale, Hamilton Depression Scale, Life Stressor Checklist, and Lifetime Drinking History. Magnetic resonance imaging data were acquired with a 1.5-T scanner and analyzed with automated and semiautomated image processing techniques. RESULTS: Eighty-two veterans had lifetime PTSD, 44 had current PTSD, and 38 had current depression. In the linear regression analysis, current PTSD symptoms (standardized coefficient β = -.25, p = .03) but neither lifetime PTSD symptoms nor current depression were associated with smaller hippocampal volume. Gender, age, history of early life trauma, education, lifetime and current alcohol use, current marijuana use, and treatment with antidepressants did not have independent effects. Participants with chronic PTSD had, on average, a smaller hippocampus compared with those with remitted PTSD. CONCLUSIONS: The finding that current but not lifetime PTSD symptom severity explains hippocampal size raises two possibilities: either a small hippocampus is a risk factor for lack of recovery from PTSD (trait) or PTSD effects on hippocampal volume are reversible once PTSD symptoms remit and the patient recovers (state).
Authors: Zhen Wang; Thomas C Neylan; Susanne G Mueller; Maryann Lenoci; Diana Truran; Charles R Marmar; Michael W Weiner; Norbert Schuff Journal: Arch Gen Psychiatry Date: 2010-03
Authors: Frank-Gerald Pajonk; Thomas Wobrock; Oliver Gruber; Harald Scherk; Dorothea Berner; Inge Kaizl; Astrid Kierer; Stephanie Müller; Martin Oest; Tim Meyer; Martin Backens; Thomas Schneider-Axmann; Allen E Thornton; William G Honer; Peter Falkai Journal: Arch Gen Psychiatry Date: 2010-02
Authors: M Sala; J Perez; P Soloff; S Ucelli di Nemi; E Caverzasi; J C Soares; P Brambilla Journal: Eur Neuropsychopharmacol Date: 2004-10 Impact factor: 4.600
Authors: P J Lucassen; P Meerlo; A S Naylor; A M van Dam; A G Dayer; E Fuchs; C A Oomen; B Czéh Journal: Eur Neuropsychopharmacol Date: 2010-01 Impact factor: 4.600
Authors: Michael W Weiner; Karl E Friedl; Anthony Pacifico; Julie C Chapman; Michael S Jaffee; Deborah M Little; Geoffrey T Manley; Ann McKee; Ronald C Petersen; Roger K Pitman; Kristine Yaffe; Henrik Zetterberg; Robert Obana; Lisa J Bain; Maria C Carrillo Journal: Alzheimers Dement Date: 2013-07 Impact factor: 21.566
Authors: Hong Xie; Meredith Claycomb Erwin; Jon D Elhai; John T Wall; Marijo B Tamburrino; Kristopher R Brickman; Brian Kaminski; Samuel A McLean; Israel Liberzon; Xin Wang Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2017-12-08
Authors: Michael W Weiner; Dieter J Meyerhoff; Thomas C Neylan; Jennifer Hlavin; Erin R Ramage; Daniel McCoy; Colin Studholme; Valerie Cardenas; Charles Marmar; Diana Truran; Philip W Chu; John Kornak; Clement E Furlong; Charles McCarthy Journal: Mil Med Date: 2011-08 Impact factor: 1.437
Authors: Brian S Mohlenhoff; Linda L Chao; Shannon T Buckley; Michael W Weiner; Thomas C Neylan Journal: Alzheimers Dement Date: 2014-06 Impact factor: 21.566
Authors: U Dannlowski; H J Grabe; K Wittfeld; J Klaus; C Konrad; D Grotegerd; R Redlich; T Suslow; N Opel; P Ohrmann; J Bauer; P Zwanzger; I Laeger; C Hohoff; V Arolt; W Heindel; M Deppe; K Domschke; K Hegenscheid; H Völzke; D Stacey; H Meyer Zu Schwabedissen; H Kugel; B T Baune Journal: Mol Psychiatry Date: 2014-04-29 Impact factor: 15.992